Site Management (SMO)

Research-ready sites with experienced investigators and dedicated, GCP-trained coordinators — managed to one quality standard.

As a site management organization, we take operational responsibility for running studies at our partner hospitals. Investigators can focus on patient care and medical judgement while our coordinators handle the protocol logistics.

What our site teams do

Coordinators manage screening logs, informed consent documentation, visit scheduling, investigational product accountability, sample handling, source documentation and timely data entry.

Consistent quality across sites

All sites operate under common SOPs, receive regular GCP refresher training and are audited by our internal quality assurance team.

What is included

  • Experienced PIs and sub-investigators
  • Dedicated clinical research coordinators
  • Standardised SOPs across sites
  • Investigational product and sample management
  • Timely eCRF data entry and query resolution
  • Internal audits and CAPA management

Frequently asked questions

How quickly can you deliver feasibility?

We usually deliver a site-by-site feasibility assessment with realistic enrollment projections within five to seven business days of receiving a protocol synopsis under NDA.

Do you support medical device investigations?

Yes. We support pilot, pivotal and post-market clinical investigations of medical devices and in-vitro diagnostics in line with the Medical Devices Rules, 2017.

Can you work with overseas sponsors and CROs?

Absolutely. We regularly act as the local execution partner for international sponsors and CROs, supporting regulatory submissions, site management and monitoring in India.

What does your quality system look like?

We operate under a documented quality management system with SOPs, training records, internal audits, CAPA management and regular mock inspections at sites.

Ready to start your next study in India?

Share your protocol synopsis and we will return a site feasibility assessment and start-up plan — confidentially and within five business days.

  • Confidential review under NDA
  • Response within one business day
  • Direct PI and site assessment